Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy

References

• Bejarano L, Jordāo MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 2021;11(4):933–959. doi:10.1158/2159-8290.CD-20-1808
   PubMed Web of Science ®Google Scholar
• de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374–403. doi:10.1016/j.ccell.2023.02.016
   PubMed Web of Science ®Google Scholar
• Qin X, Li T, Li S, et al. The tumor biochemical and biophysical microenvironments synergistically contribute to cancer cell malignancy. Cell Mol Immunol. 2020;17(11):1186–1187. doi:10.1038/s41423-019-0282-5
   PubMed Web of Science ®Google Scholar
• Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557–4566. doi:10.1158/0008-5472.CAN-18-3962
   PubMed Web of Science ®Google Scholar
• Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541–550. doi:10.1038/s41591-018-0014-x
   PubMed Web of Science ®Google Scholar
• Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5(1):166. doi:10.1038/s41392-020-00280-x
   PubMed Web of Science ®Google Scholar
• Gong F, Yang N, Wang X, et al. Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics. Nano Today. 2020;32:100851. doi:10.1016/j.nantod.2020.100851
   Web of Science ®Google Scholar
• Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218. doi:10.1016/j.tibs.2015.12.001
   PubMed Web of Science ®Google Scholar
• Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol. 1984;2(4):343–366. doi:10.1016/S0167-8140(84)80077-8
   PubMed Web of Science ®Google Scholar
• Koltai T. The Ph paradigm in cancer. Eur J Clin Nutr. 2020;74(S1):14–19. doi:10.1038/s41430-020-0684-6
   PubMedGoogle Scholar
• Kato Y, Ozawa S, Miyamoto C, et al. Acidic extracellular microenvironment and cancer. Cancer Cell Int. 2013;13(1):89. doi:10.1186/1475-2867-13-89
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhou Y, Zhang CY, Fang T. Co-delivery of paclitaxel and doxorubicin by ph-responsive prodrug micelles for cancer therapy. Int J Nanomed. 2020;15:3319–3331. doi:10.2147/IJN.S249144
   PubMed Web of Science ®Google Scholar
• Dechsri K, Suwanchawalit C, Chitropas P, et al. Rapid microwave-assisted synthesis of pH-sensitive carbon-based nanoparticles for the controlled release of doxorubicin to cancer cells. AAPS Pharm Sci Tech. 2023;24(5):135. doi:10.1208/s12249-023-02593-w
   PubMed Web of Science ®Google Scholar
• Xia F, Hou W, Zhang C, et al. pH-responsive gold nanoclusters-based nanoprobes for lung cancer targeted near-infrared fluorescence imaging and chemo-photodynamic therapy. Acta Biomater. 2018;68:308–319. doi:10.1016/j.actbio.2017.12.034
   PubMed Web of Science ®Google Scholar
• Feng Q, Shen Y, Fu Y, et al. Self-assembly of gold nanoparticles shows microenvironment-mediated dynamic switching and enhanced brain tumor targeting. Theranostics. 2017;7(7):1875–1889. doi:10.7150/thno.18985
   PubMed Web of Science ®Google Scholar
• Zhou P, Qin J, Zhou C, et al. Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer. Biomaterials. 2019;195:86–99. doi:10.1016/j.biomaterials.2019.01.007
   PubMed Web of Science ®Google Scholar
• Wang D, Wang T, Liu J, et al. Acid-activatable versatile micelleplexes for PD-L1 blockade-enhanced cancer photodynamic immunotherapy. Nano Lett. 2016;16(9):5503–5513. doi:10.1021/acs.nanolett.6b01994
   PubMed Web of Science ®Google Scholar
• Hsu CW, Hsieh MH, Xiao MC, Chou YH, Wang TH, Chiang WH. pH-responsive polymeric micelles self-assembled from benzoic-imine-containing alkyl-modified PEGylated chitosan for delivery of amphiphilic drugs. Int J Biol Macromol. 2020;163:1106–1116. doi:10.1016/j.ijbiomac.2020.07.110
   PubMed Web of Science ®Google Scholar
• Park S, Lee WJ, Park S, Choi D, Kim S, Park N. Reversibly pH-responsive gold nanoparticles and their applications for photothermal cancer therapy. Sci Rep. 2019;9(1):20180. doi:10.1038/s41598-019-56754-8
   PubMedGoogle Scholar
• Zhai L, Luo C, Gao H, Du S, Shi J, Wang F. A dual pH-responsive DOX-encapsulated liposome combined with glucose administration enhanced therapeutic efficacy of chemotherapy for cancer. Int J Nanomed. 2021;16:3185–3199. doi:10.2147/IJN.S303874
   PubMed Web of Science ®Google Scholar
• Zhao Y, Luo Z, Li M, et al. A preloaded amorphous calcium carbonate/doxorubicin@silica nanoreactor for pH-responsive delivery of an anticancer drug. Angew Chem Int Ed Engl. 2015;54(3):919–922. doi:10.1002/anie.201408510
   PubMed Web of Science ®Google Scholar
• Chen Y, Ye D, Wu M, et al. Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive ph-triggered theranostics of cancer. Adv Mater. 2014;26(41):7019–7026. doi:10.1002/adma.201402572
   PubMed Web of Science ®Google Scholar
• Wang Y, Song S, Liu J, Liu D, Zhang H. ZnO-functionalized upconverting nanotheranostic agent: multi-modality imaging-guided chemotherapy with on-demand drug release triggered by pH. Angew Chem Int Ed Engl. 2015;54(2):536–540. doi:10.1002/anie.201409519
   PubMed Web of Science ®Google Scholar
• Shi X, Ma X, Hou M, et al. pH-Responsive unimolecular micelles based on amphiphilic star-like copolymers with high drug loading for effective drug delivery and cellular imaging. J Mater Chem B. 2017;5(33):6847–6859. doi:10.1039/C7TB01477E
   PubMed Web of Science ®Google Scholar
• Sethuraman VA, Lee MC, Bae YH. A biodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm Res. 2008;25(3):657–666. doi:10.1007/s11095-007-9480-4
   PubMed Web of Science ®Google Scholar
• Piao JG, Gao F, Li Y, et al. pH-sensitive zwitterionic coating of gold nanocages improves tumor targeting and photothermal treatment efficacy. Nano Res. 2018;11(6): 3193 3204 doi:10.1007/s12274-017-1736-7.
   Web of Science ®Google Scholar
• Yang X, Grailer JJ, Rowland IJ, et al. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. ACS Nano. 2010;4(11):6805–6817. doi:10.1021/nn101670k
   PubMed Web of Science ®Google Scholar
• Schlossbauer A, Dohmen C, Schaffert D, Wagner E, Bein T. pH-responsive release of acetal-linked melittin from SBA-15 mesoporous silica. Angew Chem Int Ed Engl. 2011;50(30):6828–6830. doi:10.1002/anie.201005120
   PubMed Web of Science ®Google Scholar
• Wu W, Yu X, Sun J, et al. Zeolitic Imidazolate Framework (ZIF-8) decorated iron oxide nanoparticles loaded doxorubicin hydrochloride for osteosarcoma treatment - in vitro and in vivo preclinical studies. Int J Nanomed. 2023;18:7985–7999. doi:10.2147/IJN.S438771
   PubMed Web of Science ®Google Scholar
• Zheng H, Zhang Y, Liu L, et al. One-pot synthesis of metal-organic frameworks with encapsulated target molecules and their applications for controlled drug delivery. J Am Chem Soc. 2016;138(3):962–968. doi:10.1021/jacs.5b11720
   PubMed Web of Science ®Google Scholar
• Sun X, Du R, Zhang L, et al. A pH-responsive yolk-like nanoplatform for tumor targeted dual-mode magnetic resonance imaging and chemotherapy. ACS Nano. 2017;11(7):7049–7059. doi:10.1021/acsnano.7b02675
   PubMed Web of Science ®Google Scholar
• Liu J, Ma H, Wei T, Liang XJ. CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells. Chem Commun. 2012;48(40):4869–4871. doi:10.1039/c2cc31697h
   PubMed Web of Science ®Google Scholar
• Chung MF, Liu HY, Lin KJ, Chia WT, Sung HW. A pH-Responsive carrier system that generates NO bubbles to trigger drug release and reverse P-glycoprotein-mediated multidrug resistance. Angew Chem Int Ed Engl. 2015;54(34):9890–9893. doi:10.1002/anie.201504444
   PubMed Web of Science ®Google Scholar
• Wei D, Sun Y, Zhu H, Fu Q. Stimuli-responsive polymer-based nanosystems for cancer theranostics. ACS nano. 2023;17(23):23223–23261. doi:10.1021/acsnano.3c06019
   PubMed Web of Science ®Google Scholar
• Ahn B, Lee S-G, Yoon HR, et al. Four-fold channel-nicked human ferritin nanocages for active drug loading and pH-responsive drug release. Angew Chem Int Ed Engl. 2018;57(11):2909–2913. doi:10.1002/anie.201800516
   PubMed Web of Science ®Google Scholar
• Cheng CJ, Bahal R, Babar IA, et al. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature. 2015;518(7537):107–110. doi:10.1038/nature13905
   PubMed Web of Science ®Google Scholar
• Jia N, Ye Y, Wang Q, et al. Preparation and evaluation of poly(l-histidine) based pH-sensitive micelles for intracellular delivery of doxorubicin against MCF-7/ADR cells. Asian J Pharm Sci. 2017;12(5):433–441. doi:10.1016/j.ajps.2017.05.007
   PubMed Web of Science ®Google Scholar
• Kim J, Lee YM, Kang Y, Kim WJ. Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics. ACS Nano. 2014;8(9):9358–9367. doi:10.1021/nn503349g
   PubMed Web of Science ®Google Scholar
• Xiao X, Liang S, Zhao Y, et al. Core-shell structured 5-FU@ZIF-90@ZnO as a biodegradable nanoplatform for synergistic cancer therapy. Nanoscale. 2020;12(6):3846–3854. doi:10.1039/C9NR09869K
   PubMed Web of Science ®Google Scholar
• Zheng C, Wang Y, Phua SZF, Lim WQ, Zhao Y. ZnO-DOX@ZIF-8 core-shell nanoparticles for pH-responsive drug delivery. ACS Biomater Sci Eng. 2017;3(10):2223–2229. doi:10.1021/acsbiomaterials.7b00435
   PubMed Web of Science ®Google Scholar
• Lee ES, Shin HJ, Na K, Bae YH. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release. 2003;90(3):363–374. doi:10.1016/S0168-3659(03)00205-0
   PubMed Web of Science ®Google Scholar
• Ling D, Park W, Park SJ, et al. Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors. J Am Chem Soc. 2014;136(15):5647–5655. doi:10.1021/ja4108287
   PubMed Web of Science ®Google Scholar
• Licciardi M, Tang Y, Billingham NC, Armes SP, Lewis AL. Synthesis of novel folic acid-functionalized biocompatible block copolymers by atom transfer radical polymerization for gene delivery and encapsulation of hydrophobic drugs. Biomacromolecules. 2005;6(2):1085–1096. doi:10.1021/bm049271i
   PubMed Web of Science ®Google Scholar
• Jiang X, Wang J, Zheng X, et al. Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy. J Immunother Cancer. 2022;10(5):e003960. doi:10.1136/jitc-2021-003960
   PubMed Web of Science ®Google Scholar
• Luo M, Wang H, Wang Z, et al. A STING-activating nanovaccine for cancer immunotherapy. Nat Nanotechnol. 2017;12(7):648–654. doi:10.1038/nnano.2017.52
   PubMed Web of Science ®Google Scholar
• Han SK, Na K, Bae YH. Sulfonamide based pH-sensitive polymeric micelles: physicochemical characteristics and pH-dependent aggregation. Colloids Surface A. 2003;214(1–3):49–59. doi:10.1016/S0927-7757(02)00389-8
   Google Scholar
• Zhuang J, Kuo CH, Chou LY, Liu DY, Weerapana E, Tsung CK. Optimized metal-organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation. ACS Nano. 2014;8(3):2812–2819. doi:10.1021/nn406590q
   PubMed Web of Science ®Google Scholar
• Reshetnyak YK, Andreev OA, Segala M, Markin VS, Engelman DM. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc Natl Acad Sci U S A. 2008;105(40):15340–15345. doi:10.1073/pnas.0804746105
   PubMed Web of Science ®Google Scholar
• Andreev OA, Engelman DM, Reshetnyak YK. Targeting diseased tissues by pHLIP insertion at low cell surface pH. Front Physiol. 2014;5:97. doi:10.3389/fphys.2014.00097
   PubMed Web of Science ®Google Scholar
• Andreev OA, Karabadzhak AG, Weerakkody D, Andreev GO, Engelman DM, Reshetnyak YK. pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path. Proc Natl Acad Sci U S A. 2010;107(9):4081–4086. doi:10.1073/pnas.0914330107
   PubMed Web of Science ®Google Scholar
• Andreev OA, Dupuy AD, Segala M, et al. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc Natl Acad Sci U S A. 2007;104(19):7893–7898. doi:10.1073/pnas.0702439104
   PubMed Web of Science ®Google Scholar
• Macholl S, Morrison MS, Iveson P, et al. In vivo pH imaging with (99m)Tc-pHLIP. Mol Imaging Biol. 2012;14(6):725–734. doi:10.1007/s11307-012-0549-z
   PubMed Web of Science ®Google Scholar
• Daumar P, Wanger-Baumann CA, Pillarsetty N, et al. Efficient (18) F-labeling of Large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Bioconjug Chem. 2012;23(8):1557–1566. doi:10.1021/bc3000222
   PubMed Web of Science ®Google Scholar
• Vāvere AL, Biddlecombe GB, Spees WM, et al. A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res. 2009;69(10):4510–4516. doi:10.1158/0008-5472.CAN-08-3781
   PubMed Web of Science ®Google Scholar
• An M, Wijesinghe D, Andreev OA, Reshetnyak YK, Engelman DM. pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. Proc Natl Acad Sci U S A. 2010;107(47):20246–20250. doi:10.1073/pnas.1014403107
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen H. Recent deveolpment of multifunctional responsive gas-releasing nanoplatforms for tumor therapeutic application. Nano Res. 2023;16(3):3924–3938. doi:10.1007/s12274-022-4473-5
   Web of Science ®Google Scholar
• Cui C-Y, Li B, Su X-C. Real-time monitoring of the level and activity of intracellular glutathione in live cells at atomic resolution by 19F-NMR. ACS Cent. Sci. 2023;9(8):1623–1632. doi:10.1021/acscentsci.3c00385
   PubMedGoogle Scholar
• Raza A, Hayat U, Rasheed T, Bilal M, Iqbal HMN. Redox-responsive nano-carriers as tumor-targeted drug delivery systems. Eur J Med Chem. 2018;157:705–715. doi:10.1016/j.ejmech.2018.08.034
   PubMed Web of Science ®Google Scholar
• Niu B, Liao K, Zhou Y, et al. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021;277:121110. doi:10.1016/j.biomaterials.2021.121110
   PubMed Web of Science ®Google Scholar
• Ding Y, Pan Q, Gao W, Pu Y, Luo K, He B. Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy. Biomater. Sci. 2023;11(4):1182–1214. doi:10.1039/d2bm01833k
   PubMed Web of Science ®Google Scholar
• Perry RR, Mazetta JA, Levin M, Barranco SC. Glutathione levels and variability in breast tumors and normal tissue. Cancer. 1993;72(3):783–787. doi:10.1002/1097-0142(19930801)72:3<783::AID-CNCR2820720325>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Taleghani AS, Nakhjiri AT, Khakzad MJ, et al. Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: A review. J Mol Liq. 2021;328:115417. doi:10.1016/j.molliq.2021.115417
   Web of Science ®Google Scholar
• Sierra-Mondragon E, Molina-Jijon E, Namorado-Tonix C, Rodríguez-Muñoz R, Pedraza-Chaverri J, Reyes JL. All-trans retinoic acid ameliorates inflammatory response mediated by TLR4/NF-κB during initiation of diabetic nephropathy. J Nutr Biochem. 2018;60:47–60. doi:10.1016/j.jnutbio.2018.06.002
   PubMed Web of Science ®Google Scholar
• Ling X, Chen X, Riddell IA, et al. Glutathione-Scavenging poly(disulfide amide) nanoparticles for the effective delivery of Pt(IV) prodrugs and reversal of cisplatin resistance. Nano Lett. 2018;18(7):4618–4625. doi:10.1021/acs.nanolett.8b01924
   PubMed Web of Science ®Google Scholar
• Tu Y, Peng F, White PB, Wilson DA. Redox-sensitive stomatocyte nanomotors: destruction and drug release in the presence of glutathione. Angew Chem Int Ed Engl. 2017;56(26):7620–7624. doi:10.1002/anie.201703276
   PubMed Web of Science ®Google Scholar
• Du X, Xiong L, Dai S, Qiao SZ. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release. Adv Healthc Mater. 2015;4(5):771–781. doi:10.1002/adhm.201400726
   PubMed Web of Science ®Google Scholar
• Sun B, Luo C, Yu H, et al. Disulfide bond-driven oxidation- and reduction-responsive prodrug nanoassemblies for cancer therapy. Nano Lett. 2018;18(6):3643–3650. doi:10.1021/acs.nanolett.8b00737
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu L, Wang Y, et al. Ultrasensitive GSH-responsive ditelluride-containing poly(ether-urethane) nanoparticles for controlled drug release. ACS Appl Mater Interfaces. 2016;8(51):35106–35113. doi:10.1021/acsami.6b14639
   PubMed Web of Science ®Google Scholar
• Criado-Gonzalez M, Mecerreyes D. Thioether-based ROS responsive polymers for biomedical applications. J Mater Chem B. 2022;10(37):7206–7221. doi:10.1039/D2TB00615D
   PubMed Web of Science ®Google Scholar
• Jing F, Guo Q, Xu W, Qu H, Sui Z. Docetaxel prodrug self-assembled nanosystem: synthesis, formulation and cytotoxicity. Bioorg Med Chem Lett. 2018;28(4):826–830. doi:10.1016/j.bmcl.2017.07.041
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Liu D, et al. Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett. 2016;16(9):5401–5408. doi:10.1021/acs.nanolett.6b01632
   PubMed Web of Science ®Google Scholar
• Cao W, Wang L, Xu H. Selenium/tellurium containing polymer materials in nanobiotechnology. Nano Today. 2015;10(6):717–736. doi:10.1016/j.nantod.2015.11.004
   Web of Science ®Google Scholar
• Hu S, Jiang H, Zhu J, et al. Tumor-specific fluorescence activation of rhodamine isothiocyanate derivatives. J Control Release. 2021;330:842–850. doi:10.1016/j.jconrel.2020.10.057
   PubMed Web of Science ®Google Scholar
• Chang Y, Yang K, Wei P, et al. Cationic vesicles based on amphiphilic pillar[5]arene capped with ferrocenium: a redox-responsive system for drug/siRNA co-delivery. Angew Chem Int Ed Engl. 2014;53(48):13126–13130. doi:10.1002/anie.201407272
   PubMed Web of Science ®Google Scholar
• Mao H, Xie Y, Ju H, et al. Design of tumor microenvironment-responsive drug-drug micelle for cancer radiochemotherapy. ACS Appl Mater Interfaces. 2018;10(40):33923–33935. doi:10.1021/acsami.8b11159
   PubMed Web of Science ®Google Scholar
• Li S, Zhang T, Xu W, et al. Sarcoma-targeting peptide-decorated polypeptide nanogel intracellularly delivers shikonin for upregulated osteosarcoma necroptosis and diminished pulmonary metastasis. Theranostics. 2018;8(5):1361–1375. doi:10.7150/thno.18299
   PubMed Web of Science ®Google Scholar
• Wang X, Cai X, Hu J, et al. Glutathione-triggered “off-on” release of anticancer drugs from dendrimer-encapsulated gold nanoparticles. J Am Chem Soc. 2013;135(26):9805–9810. doi:10.1021/ja402903h
   PubMed Web of Science ®Google Scholar
• Ma B, Guo S, Nishina Y, Bianco A. Reaction between graphene oxide and intracellular glutathione affects cell viability and proliferation. ACS Appl Mater Interfaces. 2021;13(3):3528–3535. doi:10.1021/acsami.0c17523
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang L, Zhao J, He M, Huang Y, Zhao S. A tumor microenvironment-induced absorption red-shifted polymer nanoparticle for simultaneously activated photoacoustic imaging and photothermal therapy. Sci Adv. 2021;7(12):eabe3588 doi:10.1126/sciadv.abe3588.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao L, Xu X, et al. Hydrophobic cysteine poly(disulfide)-based redox-hypersensitive nanoparticle platform for cancer theranostics. Angew Chem Int Ed Engl. 2015;54(32):9218–9223. doi:10.1002/anie.201503863
   PubMed Web of Science ®Google Scholar
• Zhang S, Guan J, Sun M, et al. Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy. Drug Deliv. 2017;24(1):1460–1469. doi:10.1080/10717544.2017.1381201
   PubMed Web of Science ®Google Scholar
• Bulmus V, Woodward M, Lin L, Murthy N, Stayton P, Hoffman A. A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J Control Release. 2003;93(2):105–120. doi:10.1016/j.jconrel.2003.06.001
   PubMed Web of Science ®Google Scholar
• Cheng H, Wang X, Liu X, et al. An effective NIR laser/tumor-microenvironment co-responsive cancer theranostic nanoplatform with multi-modal imaging and therapies. Nanoscale. 2021;13(24):10816–10828. doi:10.1039/D1NR01645H
   PubMed Web of Science ®Google Scholar
• Du L, He H, Xiao Z, et al. GSH-responsive metal-organic framework for intratumoral release of NO and IDO inhibitor to enhance antitumor immunotherapy. Small. 2022;18(15):e2107732. doi:10.1002/smll.202107732
   PubMed Web of Science ®Google Scholar
• Yu M, Cao R, Ma Z, Zhu M. Development of “smart” drug delivery systems for chemo/PDT synergistic treatment. J Mat Chem B. 2023;11(7):1416–1433. doi:10.1039/D2TB02248F
   PubMed Web of Science ®Google Scholar
• Yang B, Wang K, Zhang D, et al. Polydopamine-modified ROS-responsive prodrug nanoplatform with enhanced stability for precise treatment of breast cancer. RSC Adv. 2019;9(16):9260–9269. doi:10.1039/C9RA01230C
   PubMed Web of Science ®Google Scholar
• Xu H, Cao W, Zhang X. Selenium-containing polymers: promising biomaterials for controlled release and enzyme mimics. Acc Chem Res. 2013;46(7):1647–1658. doi:10.1021/ar4000339
   PubMed Web of Science ®Google Scholar
• Wang L, Fan F, Cao W, Xu H. Ultrasensitive ROS-responsive coassemblies of tellurium-containing molecules and phospholipids. ACS Appl Mater Interfaces. 2015;7(29):16054–16060. doi:10.1021/acsami.5b04419
   PubMed Web of Science ®Google Scholar
• Deepagan VG, Kwon S, You DG, et al. In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery. Biomaterials. 2016;103:56–66. doi:10.1016/j.biomaterials.2016.06.044
   PubMed Web of Science ®Google Scholar
• Wang L, Cao W, Yi Y, Xu H. Dual redox responsive coassemblies of diselenide-containing block copolymers and polymer lipids. Langmuir. 2014;30(19):5628–5636. doi:10.1021/la501054z
   PubMed Web of Science ®Google Scholar
• Xu X, Saw PE, Tao W, et al. ROS-responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy. Adv Mat. 2017;29(33):1700141 doi:10.1002/adma.201700141.
   Web of Science ®Google Scholar
• da Silva DA, De Luca A, Squitti R, et al. Copper in tumors and the use of copper-based compounds in cancer treatment. J Inorg Biochem. 2022;226:111634. doi:10.1016/j.jinorgbio.2021.111634
   PubMed Web of Science ®Google Scholar
• Daund V, Chalke S, Sherje AP, Kale PP. ROS responsive mesoporous silica nanoparticles for smart drug delivery: A review. J Drug Delivery Sci Technol. 2021;64:102599. doi:10.1016/j.jddst.2021.102599
   Web of Science ®Google Scholar
• Sun Y, Wang Z, Zhang P, et al. Mesoporous silica integrated with Fe3O4 and palmitoyl ascorbate as a new nano-Fenton reactor for amplified tumor oxidation therapy. Biomater Sci. 2020;8(24):7154–7165. doi:10.1039/D0BM01738H
   PubMed Web of Science ®Google Scholar
• Hu J-J, Lei Q, Peng M-Y, Zheng D-W, Chen Y-X, Zhang X-Z. A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem. Biomaterials. 2017;128:136–146. doi:10.1016/j.biomaterials.2017.03.010
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang X, Zhong W, Ren X, Sha X, Fang X. Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation. Int J Nanomed. 2016;11:1643–1661. doi:10.2147/IJN.S101030
   PubMed Web of Science ®Google Scholar
• Grünwald B, Vandooren J, Locatelli E, et al. Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. J Control Release. 2016;239:39–48. doi:10.1016/j.jconrel.2016.08.016
   PubMed Web of Science ®Google Scholar
• Wickström M, Larsson R, Nygren P, Gullbo J. Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Sci. 2011;102(3):501–508. doi:10.1111/j.1349-7006.2010.01826.x
   PubMed Web of Science ®Google Scholar
• Yang L, Li Y, Ding Y, Choi KS, Kazim AL, Zhang Y. Prolidase directly binds and activates epidermal growth factor receptor and stimulates downstream signaling. J Biol Chem. 2013;288(4):2365–2375. doi:10.1074/jbc.M112.429159
   PubMed Web of Science ®Google Scholar
• Linkous A, Geng L, Lyshchik A, Hallahan DE, Yazlovitskaya EM. Cytosolic phospholipase A2: targeting cancer through the tumor vasculature. Clin Cancer Res. 2009;15(5):1635–1644. doi:10.1158/1078-0432.CCR-08-1905
   PubMed Web of Science ®Google Scholar
• Li H, Yu SS, Miteva M, et al. Matrix metalloproteinase responsive, proximity-activated polymeric nanoparticles for siRNA delivery. Adv Funct Mater. 2013;23(24):3040–3052. doi:10.1002/adfm.201202215
   PubMed Web of Science ®Google Scholar
• Secret E, Kelly SJ, Crannell KE, Andrew JS. Enzyme-responsive hydrogel microparticles for pulmonary drug delivery. ACS Appl. Mater. Interfaces. 2014;6(13):10313–10321. doi:10.1021/am501754s
   PubMed Web of Science ®Google Scholar
• Gondi CS, Rao JS. Cathepsin B as a cancer target. Expert Opin Ther Targets. 2013;17(3):281–291. doi:10.1517/14728222.2013.740461
   PubMed Web of Science ®Google Scholar
• Hsu CW, Olabisi RM, Olmsted-Davis EA, Davis AR, West JL. Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in response to bone resorption. J Biomed Mater Res A. 2011;98(1):53–62. doi:10.1002/jbm.a.33076
   PubMedGoogle Scholar
• Bughda R, Dimou P, RR D, Klampatsa A. Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: launching an attack on tumor stroma. Immunotargets Ther. 2021;10:313–323. doi:10.2147/ITT.S291767
   PubMed Web of Science ®Google Scholar
• Rastegari B, Karbalaei-Heidari HR, Zeinali S, Sheardown H. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: synthesis, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2017;158:589–601. doi:10.1016/j.colsurfb.2017.07.044
   PubMed Web of Science ®Google Scholar
• Chau Y, Zhong J. Enzyme-sensitive biomaterials for drug delivery. Comprehensive Biotechnol. 2019;5:501–519 doi:10.1016/B978-0-444-64046-8.00310-4.
   Google Scholar
• Fan Y, Yuan S, Huo M, et al. Spatial controlled multistage nanocarriers through hybridization of dendrimers and gelatin nanoparticles for deep penetration and therapy into tumor tissue. Nanomedicine. 2017;13(4):1399–1410. doi:10.1016/j.nano.2017.01.008
   PubMed Web of Science ®Google Scholar
• Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70. doi:10.1038/s41392-023-01332-8
   PubMed Web of Science ®Google Scholar
• Lin Q, Bao C, Yang Y, et al. Highly discriminating photorelease of anticancer drugs based on hypoxia activatable phototrigger conjugated chitosan nanoparticles. Adv Mater. 2013;25(14):1981–1986. doi:10.1002/adma.201204455
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao L, Li XF. The hypoxia-activated prodrug TH-302: exploiting hypoxia in cancer therapy. Front Pharmacol. 2021;12:636892. doi:10.3389/fphar.2021.636892
   PubMed Web of Science ®Google Scholar
• Joshi U, Filipczak N, Khan MM, Attia SA, Torchilin V. Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells. Int J Pharm. 2020;590:119915. doi:10.1016/j.ijpharm.2020.119915
   PubMed Web of Science ®Google Scholar
• Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem. 1994;140(1):1–22. doi:10.1007/BF00928361
   PubMed Web of Science ®Google Scholar
• Lai J, Shah BP, Zhang Y, Yang L, Lee KB. Real-time monitoring of ATP-responsive drug release using mesoporous-silica-coated multicolor upconversion nanoparticles. ACS Nano. 2015;9(5):5234–5245. doi:10.1021/acsnano.5b00641
   PubMed Web of Science ®Google Scholar
• Naito M, Ishii T, Matsumoto A, Miyata K, Miyahara Y, Kataoka K. A phenylboronate-functionalized polyion complex micelle for ATP-triggered release of siRNA. Angew Chem Int Ed Engl. 2012;51(43):10751–10755. doi:10.1002/anie.201203360
   PubMed Web of Science ®Google Scholar
• Shen HK, Morishita K, Hashim PK, et al. ATP-responsive nanoparticles covered with biomolecular machine “Chaperonin GroEL”. Angew Chem Int Ed Engl. 2023;62(31):e202304894. doi:10.1002/anie.202304894
   PubMed Web of Science ®Google Scholar
• Sameiyan E, Bagheri E, Dehghani S, et al. Aptamer-based ATP-responsive delivery systems for cancer diagnosis and treatment. Acta Biomater. 2021;123:110–122. doi:10.1016/j.actbio.2020.12.057
   PubMed Web of Science ®Google Scholar
• Kim J, Lee YM, Kim H, Park D, Kim J, Kim WJ. Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy. Biomaterials. 2016;75:102–111. doi:10.1016/j.biomaterials.2015.10.022
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang Q, Zhang M, et al. ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy. Theranostics. 2018;8(17):4604–4619. doi:10.7150/thno.26889
   PubMed Web of Science ®Google Scholar
• Duan H, Li L, Zou K, Deng Y, Chen G. Cyclodextrin-integrated PEO-Based composite solid electrolytes for high-rate and ultrastable all-solid-state lithium batteries. ACS Appl Mater Interfaces. 2021;13(48):57380–57391. doi:10.1021/acsami.1c18589
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Y, Chen J, et al. Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA. Int J Nanomed. 2017;12:4721–4732. doi:10.2147/IJN.S135086
   PubMed Web of Science ®Google Scholar
• Chen WH, Yu X, Cecconello A, Sohn YS, Nechushtai R, Willner I. Stimuli-responsive nucleic acid-functionalized metal-organic framework nanoparticles using pH- and metal-ion-dependent DNAzymes as locks. Chem Sci. 2017;8(8):5769–5780. doi:10.1039/C7SC01765K
   PubMed Web of Science ®Google Scholar
• Ye Z, Jiang Y, Li L, Wu F, Chen R. Rational design of MOF-based materials for next-generation rechargeable batteries. Nanomicro Lett. 2021;13(1):203. doi:10.1007/s40820-021-00726-z
   PubMed Web of Science ®Google Scholar
• Mo R, Jiang T, DiSanto R, Tai W, Gu Z. ATP-triggered anticancer drug delivery. Nat Commun. 2014;5:3364. doi:10.1038/ncomms4364
   PubMed Web of Science ®Google Scholar
• Qian C, Chen Y, Zhu S, et al. ATP-responsive and near-infrared-emissive nanocarriers for anticancer drug delivery and real-time imaging. Theranostics. 2016;6(7):1053–1064. doi:10.7150/thno.14843
   PubMed Web of Science ®Google Scholar
• Chen W-H, Yu X, Liao W-C, et al. ATP-responsive aptamer-based metal–organic framework Nanoparticles (NMOFs) for the controlled release of loads and drugs. Adv Funct Mat. 2017;27:1702102 doi:10.1007/s12274-017-1736-7.
   Web of Science ®Google Scholar
• Ren H, Hu Q, Sun Y, et al. Surface chemistry mediates the tumor entrance of nanoparticles probed using single-molecule dual-imaging nanodots. Biomater Sci. 2023;11(21):7051–7061. doi:10.1039/D3BM01171B
   PubMed Web of Science ®Google Scholar
• Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183–3195. doi:10.7150/thno.52570
   PubMed Web of Science ®Google Scholar
• Liang Y, Iqbal Z, Lu J, et al. Cell-derived nanovesicle-mediated drug delivery to the brain: principles and strategies for vesicle engineering. Mol Ther. 2023;31(5):1207–1224. doi:10.1016/j.ymthe.2022.10.008
   PubMed Web of Science ®Google Scholar
• Liu Q, Li D, Pan X, Liang Y. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. J Nanobiotechnol. 2023;21(1):334. doi:10.1186/s12951-023-02081-0
   PubMed Web of Science ®Google Scholar
• Xu X, Xu L, Wen C, Xia J, Zhang Y, Liang Y. Programming assembly of biomimetic exosomes: an emerging theranostic nanomedicine platform. Mater Today Bio. 2023;22:100760. doi:10.1016/j.mtbio.2023.100760
   PubMedGoogle Scholar